gms | German Medical Science

Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2016)

25.10. - 28.10.2016, Berlin

Fetuin-A serum concentration as predictor of long-term outcome after hip fracture in osteoporotic patients

Meeting Abstract

  • presenting/speaker Claas Jasper Steffen - Chirurgische Klinik der Universitätsmedizin Rostock, Unfall-, Hand- und Wiederherstellungschirurgie, Rostock, Germany
  • Norina Cornelius - Chirurgische Klinik der Universitätsmedizin Rostock, Unfall-, Hand- und Wiederherstellungschirurgie, Rostock, Germany
  • Philipp Herlyn - Chirurgische Klinik der Universitätsmedizin Rostock, Unfall-, Hand- und Wiederherstellungschirurgie, Rostock, Germany
  • Thomas Mittlmeier - Chirurgische Klinik der Universitätsmedizin Rostock, Unfall-, Hand- und Wiederherstellungschirurgie, Rostock, Germany
  • Dagmar-Christiane Fischer - Universitäts-Kinder- und Jugendklinik, Rostock., Rostock, Germany

Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2016). Berlin, 25.-28.10.2016. Düsseldorf: German Medical Science GMS Publishing House; 2016. DocPO12-341

doi: 10.3205/16dkou545, urn:nbn:de:0183-16dkou5451

Veröffentlicht: 10. Oktober 2016

© 2016 Steffen et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Text

Objectives: Osteoporotic hip fractures are associated with high postoperative mortality and subsequently reduced physical function. Fetuin-A is a multifunctional protein that acts as an inhibitor of ectopic calcification while favoring mineralization of bone. Epidemiological studies in elderly women showed an association between Fetuin-A serum levels and BMD. In this retrospective follow-up study we investigated the relation between Fetuin-A serum concentrations and long-term outcome after hip fractures.

Methods: Recently, we analysed bone microarchitecture and kinetics of Fetuin-A at time of fracture (t0) and during postoperative recovery (t1 and t2) in osteoporotic patients presenting with low energy hip fracture [J Clin Densitom 2014]. Roughly 2 years later we re-examined this patient cohort with respect to Fetuin-A serum levels, anthropometric and clinical characteristics, i. e. Harris Hip Score and Merle d'Aubigné and Postel Score, Timed up and go test, Chair rising test, Tandem-stand test and handgrip strength were determined. A trauma centered History of disease including fractures and falls was derived from chart review and interview. A summary score ("overall outcome") was developed and a Principal Components Analysis enabeld us to summarize physical performance as one variable. All data are given as mean ± SDEV. P-values are two-sided and a value below 0.05 was considered significant.

Results and Conclusion: From the patients enrolled previously, 58 (15m/43f; patients (78.8 ± 11.3 years) were still alive and 46 (14m/32f; 80.2 ± 11.7 years) consented to participate. Both of the newly defined variables, i.e. overall outcome and physical performance were positively associated with perioperative serum concentrations of Fetuin-A (t2: r=0.55 and r=0.54 respectively, each p<0.01). Multiple linear regression analysis revealed Fetuin-A serum concentration at t1 and t2 as independent predictors of physical performance.

Perioperative Fetuin-A serum concentrations may serve as predictor of functional outcome in patients with low energy hip fractures.